(Z)-5-(4-trifluoromethylbenzylidene)thiazolidine-2,4-dione | 438190-32-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (Z)-5-(4-trifluoromethylbenzylidene)thiazolidine-2,4-dione
• 英文别名: (Z)-5-(4-(Trifluoromethyl)benzylidene)thiazolidine-2,4-dione；(5Z)-5-[[4-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione
• CAS: 438190-32-0
• 化学式: C₁₁H₆F₃NO₂S
• 分子量: 273.235
• InChiKey: GHXXZGKRRQQPIS-YVMONPNESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  71.5
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (Z)-5-(4-trifluoromethylbenzylidene)thiazolidine-2,4-dione 在 氢溴酸 、 sodium hydride 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 31.17h， 生成 N-(allyloxy)-2-((2,4-dioxo-5-(4-trifluoromethyl)benzylidene)thiazolidin-3-yl)acetamide
  参考文献：
  名称：

  Novel thiazolidinedione-hydroxamates as inhibitors of Mycobacterium tuberculosis virulence factor Zmp1

  摘要：

  Zinc metalloprotease 1 (Zmp1) is an extracellular enzyme, which has been found essential for the intracellular survival and pathogenesis of Mycobacterium tuberculosis. In this work, we designed and synthesized a series of novel thiazolidinedione-hydroxamates and evaluated in silica their drug-likeness behavior. Then, their inhibitory properties towards a recombinant Zmp1 from Mycobacterium tuberculosis were analyzed by MALDI-TOF MS. Nine of the tested compounds were found to inhibit the enzymatic reaction more effectively than the generic metalloprotease inhibitor phosphoramidon. Furthermore, the synthesized thiazolidinedione-hydroxamate hybrids were evaluated for their in vitro antimycobacterial activity and acute cytotoxicity using whole-cell assays. Results showed that none of the hybrids exhibited acute cytotoxicity against RAW264.7 macrophages. Whereas extracellular antimycobacterial activity was limited, RAW264.7 macrophage infection results showed that a majority of the hybrids inhibited the intracellular growth of Mycobacterium tuberculosis at a concentration of 100 and 10 mu M. The thiazolidinedione-hydroxamate compound 2n was considered to be the best candidate of the evaluated library. (C) 2019 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2019.111812
• 作为产物：
  描述：

  对三氟甲基苯甲醛 、 2,4-噻唑烷二酮 在 溶剂黄146 、 β-丙氨酸 作用下， 反应 8.0h， 以79%的产率得到(Z)-5-(4-trifluoromethylbenzylidene)thiazolidine-2,4-dione
  参考文献：
  名称：

  亚芳基杂环的光异构化：走向稠合杂环喹啉的形成

  摘要：

  我们在此报告了一系列亚芳基杂环1的光致异构化。通过结合 UV-vis/photo-NMR 光谱研究研究了光反应机理，我们发现 Ar-TZD 表现出正 P 型光致变色，这限制了它们的异构化效率。通过探索一系列溶剂中的溶剂致变色，研究了有利于向一种或另一种立体异构体转化的条件，特别是通过选择合适的波长。最后，通过方便地制备各种稠合杂环喹啉并以良好的总产率提出了该光异构化研究的扩展。

  DOI：

  10.1021/acs.joc.2c00748

文献信息

• Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
  作者：Zuping Xia、Christian Knaak、Jian Ma、Zanna M. Beharry、Campbell McInnes、Wenxue Wang、Andrew S. Kraft、Charles D. Smith

  DOI：10.1021/jm800937p

  日期：2009.1.8

  50 diverse protein kinases demonstrated that it has high selectivity for Pim kinases. Computational docking of 4a to Pim-1 provided a model for lead optimization, and a series of substituted thiazolidine-2,4-dione congeners was synthesized. The most potent new compounds exhibited IC50s of 13 nM for Pim-1 and 2.3 μM for Pim-2. Additional compounds in the series demonstrated selectivities of more than

  Pim 蛋白激酶在前列腺癌和某些形式的白血病和淋巴瘤中经常过度表达。5-(3-Trifluoromethylbenzylidene)thiazolidine-2,4-dione ( 4a ) 通过筛选鉴定为 Pim-1 抑制剂，并被发现可以减弱完整细胞中标记的 Pim-1 的自磷酸化。尽管4a是 ATP 的竞争性抑制剂，但对大约 50 种不同蛋白激酶的筛选表明它对 Pim 激酶具有高选择性。4a与 Pim-1 的计算对接提供了先导优化模型，并合成了一系列取代的噻唑烷-2,4-二酮同系物。最有效的新化合物表现出 IC 50Pim-1 为 13 nM，Pim-2 为 2.3 μM。该系列中的其他化合物对 Pim-1 或 Pim-2 的选择性分别超过 2500 倍和 400 倍，而其他同类物对这两种同工酶的效力基本上相同。总的来说，这些化合物是新的 Pim 激酶抑制剂，可以提供新的抗癌剂。
• Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones
  作者：G Bruno、L Costantino、C Curinga、R Maccari、F Monforte、F Nicolò、R Ottanà、M.G Vigorita

  DOI：10.1016/s0968-0896(01)00366-2

  日期：2002.4

  synthesized and tested as aldose reductase inhibitors (ARIs). The most active of the N-unsubstituted derivatives (2) exerted the same inhibitory activity of Sorbinil. The introduction of an acetic side chain on N-3 of the thiazolidinedione moiety led to a marked increase in lending inhibitory activity, conducting to the discovery of a very potent ARI (4c), whose activity level (IC50=0.13 microM) was

  合成了几种（Z）-5-芳基-2,4-噻唑烷二酮并作为醛糖还原酶抑制剂（ARIs）进行了测试。N-未取代的衍生物中活性最高的（2）发挥了索比尼尔相同的抑制活性。在噻唑烷二酮部分的N-3上引入乙酸侧链导致放贷抑制活性显着增加，从而发现了非常有效的ARI（4c），其活性水平（IC50 = 0.13 microM）处于Tolrestat的范围相同。此外，没有任何酸性官能团的相应的甲酯（3）显示出与N-未取代的化合物相似的明显的抑制活性。还发现5-亚苄基部分上的取代模式显着影响N-未取代的2,4-噻唑烷二酮2的活性。在间位具有取代基的化合物通常比对位取代的化合物更有效；但是，在乙酸3和酸4中没有发现这种SAR。
• Woollins’ reagent promotes selective reduction of α,β-unsaturated thiazo and selenazolidinones
  作者：Chiara Pizzo、Graciela Mahler

  DOI：10.1016/j.tetlet.2017.02.053

  日期：2017.4

  In this work we describe the Woollins’ reagent as useful for the selective reduction of the double bond of 2-α,β-unsaturated thiazo and selenazolidinones. The reaction took place in toluene at room temperature to give the corresponding saturated heterocycles in good yields, eleven examples are given. The scope of the reaction is also discussed, being essential the conjugated ester to the double bond

  在这项工作中，我们描述了Woollins试剂可用于选择性还原2-α，β-不饱和噻唑和亚硒唑烷酮的双键。反应在室温下在甲苯中进行，以良好的收率得到相应的饱和杂环，给出了十一个实例。还讨论了反应的范围，这是对双键的共轭酯必不可少的。
• 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles
  申请人：Tsubouchi Hidetsugu

  公开号：US20060094767A1

  公开（公告）日：2006-05-04

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R 1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R 2 represents a group —OR 3 or the like, and R 3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R 1 and —(CH 2 ) n R 2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R 41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.

  本发明提供了一种2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物，其通式如下：其中，R1代表氢原子或C1-C6烷基，n代表0到6的整数，R2代表—OR3或类似的基团，R3代表氢原子、C1-C6烷基或类似的基团，或者R1和—(CH2)nR2可以通过相邻的碳原子通过氮原子结合在一起形成一个螺环，其通式为（H）：其中，R41为氢、C1-C6烷基或类似的基团。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型酸性快速细菌具有优异的杀菌作用。
• 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP1555267A1

  公开（公告）日：2005-07-20

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group -OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and a typical acid-fast bacteria.

  本发明提供了由以下通式代表的 2，3-二氢-6-硝基咪唑并[2，1-b]恶唑化合物： 其中R1代表氢原子或C1-C6烷基，n代表0至6的整数，R2代表基团-OR3或类似基团，R3代表氢原子、C1-C6烷基或类似基团，或者R1和-(CH2)nR2可以通过氮原子与相邻的碳原子相互结合，从而形成通式(H)代表的螺环： 其中 R41 为氢、C1-C6 烷基或类似基团。本化合物对结核分枝杆菌、多重耐药结核分枝杆菌和典型的耐酸细菌有很好的杀菌作用。